Abstract:Background: Hypoxic-ischemic encephalopathy (HIE) is a major contributor to child mortality and morbidity. Reliable prognostication for HIE is of key importance. Proton magnetic resonance spectroscopy (1H-MRS) is a quantitative, non-invasive method that has been demonstrated to be a suitable complementary tool for prediction. The aim of this study was to investigate the prognostic capability of 1H-MRS in the era of therapeutic hypothermia (TH). Methods: Databases, namely MEDLINE, Embase, Web of Science, and the Cochrane library (Cochrane Center Register of Controlled Trials), were searched for studies published before July 17, 2017. Study selection and data extraction were performed by two independent reviewers. The mean difference (MD) or standardized MD (SMD) and 95% confidence interval (CI) were calculated using random-effects models. Subgroup analyses were conducted based on the use of TH. Results: Among the 1,150 relevant studies, seven were included for meta-analysis, but only two small studies were conducted under TH. For 1H-MRS measurement, three peak area ratios revealed predictive values for adverse outcomes in TH subgroup and the combined results (with and without TH): N-acetylaspartate (NAA)/creatine in basal ganglia/thalamus (BG/T) in TH (MD -0.31, 95%CI -0.55 to -0.07) and combined results (MD -0.37, 95% CI -0.49 to -0.25); NAA/choline in BG/T in TH (MD -0.89, 95%CI -1.43 to -0.35) and combined results (MD -0.25, 95%CI -0.42 to -0.07); and myo-inositol/choline in cerebral cortex in TH (MD -1.94, 95%CI -3.69 to -0.19) and combined results (MD -1.64, 95%CI -2.64 to -0.64). Moreover, NAA relative concentration is associated with adverse outcomes: in TH (MD -0.04, 95%CI -0.06 to -0.02) and combined results (MD -0.06, 95%CI -0.11 to -0.01) in white matter; in TH (MD -0.04, 95%CI -0.07 to -0.01) and combined results (MD -0.05, 95%CI -0.07 to -0.02) in gray matter. Conclusions: NAA may be a potential marker in outcome prediction for all HIE subjects. It seems that MDs for the ratios including NAA are larger than for its relative concentration, and therefore are more likely to be measurable in a clinical context. Larger prospective multicenter studies with a standardized protocol for both measurement protocols and analysis methods are required in future studies.

[Current Status of the Application of 1H-Magnetic Resonance Spectroscopy in Neonates with Hypoxic-Ischemic Encephalopathy].

Proton Magnetic Resonance Spectroscopy Biomarkers in Neonates with Hypoxic-Ischemic Encephalopathy: A Systematic Review and Meta-Analysis.

Role of Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy in the diagnosis of Neonatal Hypoxic-Ischemic Injury

Microstructural Alterations in Projection and Association Fibers in Neonatal Hypoxia-Ischemia.

Magnetic Resonance Imaging in (Near-)Term Infants with Hypoxic-Ischemic Encephalopathy

MR Imaging in Neonates with Hypoxic-ischemic Encephalopathy

Diagnostic value of the signal intensity on T1 -weighted images of MRI and 1H MRS for neonatal hypoxic-ischemic encephalopathy

Investigate the value of diffusion weighted MRI and proton MRS in early diagnosing hypoxic-ischemic encephalopathy in full-term infants

Fifty years of brain imaging in neonatal encephalopathy following perinatal asphyxia

MRI predictors of long-term outcomes of neonatal hypoxic ischaemic encephalopathy: a primer for radiologists

Magnetic resonance imaging scanning susceptibility weighted imaging sequences in the diagnosis and prognostic evaluation of neonatal hypoxic-ischemic encephalopathy

Neonatal hypoxic-ischemic encephalopathy:detection with diffusion-weighted and diffusion-tensor MR imaging

Semi-quantitative Assessment of Brain Maturation by Conventional Magnetic Resonance Imaging in Neonates with Clinically Mild Hypoxic-ischemic Encephalopathy

Exploratory Assessment of the Relationship Between Hemoglobin Volume Phase Index, Magnetic Resonance Imaging, and Functional Outcome in Neonates with Hypoxic–Ischemic Encephalopathy

Application of MR ASL perfusion weighted imaging in the diagnosis of full-term neonatal hypoxic ischemic encephalopathy

Cerebral rScO2 Measured by Near-Infrared Spectroscopy (NIRS) During Therapeutic Hypothermia in Neonates with Hypoxic-Ischemic Encephalopathy: A Systematic Review

Insights from serial magnetic resonance imaging in neonatal encephalopathy in term infants

Study in Current Status of Neonatal of Hypoxic Ischemic Encephalopathy in China by Co-Word Analysis Method

Changes of Serum Myelin Base Protein, Neuron Specific Enolase and Coronal-Ct Manifestions and Its Clinical Significance in Neonate Hypoxic Ischemic Encephalopathy

Current analysis of hypoxic-ischemic encephalopathy research issues and future treatment modalities

Altered resting-state functional connectivity in newborns with hypoxic ischemic encephalopathy assessed using high-density functional near-infrared spectroscopy